Wang and Kang NLRC4 Study

Kang Lab unravels novel therapeutic strategies for NLRC4-associated autoinflammation and infantile enterocolitis

Wednesday, January 14, 2026
Kang Lab unravels novel therapeutic strategies for NLRC4-associated autoinflammation and infantile enterocolitis, a rare but often fatal monogenic disorder characterized by severe neonatal colitis, systemic hyperinflammation, and macrophage activation syndrome (MAS).

Recent publications

A book icon

Publications: Week of January 20, 2026

Featuring: Melissa Blessing, DO; Di Hu, PhD; Hui Li, PhD; Hong Lin; Vincent Liu, MD, FAAD; Jia Luo, PhD; Osorio Lopes Abath Neto, MD, PhD; Elliot Stalter; Brian Swick, MD, FAAD; Wen Wen, PhD; Zuohui Zhang, MD, PhD; Claire Voyles
A book icon

Publications: Week of January 13, 2026

Featuring: Andrew Bellizzi, MD; Matthew Carda, DO; Kimberly Fiock, PhD; Marco Hefti, MD; Jennifer Kersigo, BS; Matthew Krasowski, MD, PhD; David Meyerholz, DVM, PhD; Osorio Lopes Abath Neto, MD, PhD; Claire Voyles
A book icon

Publications: Week of January 6, 2026

Featuring: Andrew Bellizzi, MD; Allen Choi, MD; Di Hu, PhD; Kshitija Kale, MD; Hui Li, PhD; Hong Lin; Jia Luo, PhD; David Meyerholz, DVM, PhD; Robert Robinson, MD, PhD; Wen Wen, PhD; Zuohui Zhang, MD, PhD

Under the Scope: Employee Recognition Program

Under the Scope: December 2025

December's recipients are Michael Bunney and Juan Sanchez-Ramirez

Under the Scope: October 2025

October's recipients are Tarique Abdalla and Heather Lai

Under the Scope: August 2025

August's recipient is Tracy Batley